NO20014806D0 - Kombinasjonspreparat for behandling av malaria - Google Patents

Kombinasjonspreparat for behandling av malaria

Info

Publication number
NO20014806D0
NO20014806D0 NO20014806A NO20014806A NO20014806D0 NO 20014806 D0 NO20014806 D0 NO 20014806D0 NO 20014806 A NO20014806 A NO 20014806A NO 20014806 A NO20014806 A NO 20014806A NO 20014806 D0 NO20014806 D0 NO 20014806D0
Authority
NO
Norway
Prior art keywords
treatment
malaria
combination preparation
proguanil
primaquine
Prior art date
Application number
NO20014806A
Other languages
English (en)
Other versions
NO20014806L (no
Inventor
Jeffrey David Chulay
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20014806D0 publication Critical patent/NO20014806D0/no
Publication of NO20014806L publication Critical patent/NO20014806L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20014806A 1999-04-09 2001-10-03 Kombinasjonspreparat for behandling av malaria NO20014806L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12867299P 1999-04-09 1999-04-09
PCT/US2000/009091 WO2000061133A1 (en) 1999-04-09 2000-04-05 Combination preparation for treating malaria

Publications (2)

Publication Number Publication Date
NO20014806D0 true NO20014806D0 (no) 2001-10-03
NO20014806L NO20014806L (no) 2001-12-05

Family

ID=22436426

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014806A NO20014806L (no) 1999-04-09 2001-10-03 Kombinasjonspreparat for behandling av malaria

Country Status (24)

Country Link
US (1) US6413993B1 (no)
EP (1) EP1171108B1 (no)
JP (1) JP2002541196A (no)
KR (1) KR100613805B1 (no)
CN (1) CN1152676C (no)
AT (1) ATE241971T1 (no)
AU (1) AU758167B2 (no)
BR (1) BR0009676A (no)
CA (1) CA2369089A1 (no)
CZ (1) CZ294903B6 (no)
DE (1) DE60003175T2 (no)
DK (1) DK1171108T3 (no)
ES (1) ES2199817T3 (no)
HK (1) HK1041638A1 (no)
HU (1) HUP0200842A3 (no)
IL (2) IL145609A0 (no)
MX (1) MXPA01010125A (no)
NO (1) NO20014806L (no)
NZ (1) NZ514353A (no)
PL (1) PL350987A1 (no)
PT (1) PT1171108E (no)
TR (1) TR200102843T2 (no)
WO (1) WO2000061133A1 (no)
ZA (1) ZA200108254B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
CN102088956A (zh) * 2008-05-09 2011-06-08 托马有限公司 氯胍用于治疗皮肤/粘膜疾病
US20110206770A1 (en) * 2008-07-25 2011-08-25 Alphapharm Pty. Ltd. Atovaquone with a particle size diameter range (d90) of greater than 3 microns to about 10 microns
EP2467358B1 (en) 2009-08-20 2014-07-23 IPCA Laboratories Limited Novel complex for treatment and/or prophylaxis of parasitic infections
US10966911B2 (en) * 2016-02-12 2021-04-06 Kao Corporation Melanin decomposition inhibitor
CN110022794A (zh) * 2016-10-05 2019-07-16 泰坦医药品公司 具有减少的突释的用于药物递送的可植入装置
US20200155481A1 (en) * 2017-05-03 2020-05-21 The Johns Hopkins University Intramuscular atovaquone for malaria prophylaxis
CN107737108B (zh) * 2017-12-17 2018-06-26 姚蕾 一种治疗心肌梗死后心室重塑的口服药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
JPH0873355A (ja) * 1994-09-02 1996-03-19 Mitsui Toatsu Chem Inc 抗マラリア薬耐性克服剤

Also Published As

Publication number Publication date
IL145609A0 (en) 2002-06-30
PT1171108E (pt) 2003-10-31
HUP0200842A3 (en) 2006-07-28
DE60003175T2 (de) 2004-04-01
WO2000061133A1 (en) 2000-10-19
US6413993B1 (en) 2002-07-02
IL145609A (en) 2006-04-10
ZA200108254B (en) 2003-03-26
EP1171108A1 (en) 2002-01-16
CZ20013646A3 (cs) 2002-06-12
NO20014806L (no) 2001-12-05
PL350987A1 (en) 2003-02-24
EP1171108B1 (en) 2003-06-04
DE60003175D1 (de) 2003-07-10
NZ514353A (en) 2003-10-31
KR100613805B1 (ko) 2006-08-18
MXPA01010125A (es) 2002-06-04
TR200102843T2 (tr) 2002-01-21
KR20010108468A (ko) 2001-12-07
DK1171108T3 (da) 2003-10-06
CN1346267A (zh) 2002-04-24
CZ294903B6 (cs) 2005-04-13
CN1152676C (zh) 2004-06-09
AU4202200A (en) 2000-11-14
ES2199817T3 (es) 2004-03-01
HUP0200842A2 (hu) 2002-07-29
HK1041638A1 (en) 2002-07-19
CA2369089A1 (en) 2000-10-19
BR0009676A (pt) 2002-09-03
JP2002541196A (ja) 2002-12-03
ATE241971T1 (de) 2003-06-15
AU758167B2 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
GEP20053602B (en) Aripiprazole for Oral Administration
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
DK0998287T3 (da) Anvendelse af levobupivacain
AU1167602A (en) Methods of therapy for hiv infection
NO20014806D0 (no) Kombinasjonspreparat for behandling av malaria
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
PT966285E (pt) Utilizacao de (+)mefloquina para o tratamento da malaria
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
AP9400647A0 (en) Medicaments for use in treatment of HIV or cancer patients.
AU2002304480A1 (en) Plasmodium falciparum antigens and vaccine and diagnostic uses thereof
ATE452654T1 (de) Polyalkylenoxid-konjugate von thiolhaltigen arzneistoffen
USD467344S1 (en) Treatment couch
EP1143981A4 (en) TREATMENT AND PREVENTION OF HIV AND OTHER VIRUS INFECTIONS
MXPA03010920A (es) Uso de alconil l- carnitina para preparacion de medicamento para tratar anhedonia.
MXPA03010919A (es) Uso de acetil l-carnitina para preparacion de medicamento para terapia preventiva del dolor.
HK1039935A1 (en) Use of (1r, 4s)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol in hbv
WO2003059334A3 (en) Gemcitabine in the treatment of smallpox
UA32280A (uk) Спосіб формування тонко-товстокишкового анастомозу бік у бік
RU2002115585A (ru) Способ профилактики тромбоза и инфицирования катетера, находящегося в магистральной вене
ATE326974T1 (de) Blockierung der anlagerung von keimen bei vögeln
UA32358A (uk) Спосіб лікування гіпертонічної хвороби серця
UA38042A (uk) Протифібриляторний препарат трамадол
AU2002308925A1 (en) Blood group-free human blood plasma and the preparation method thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application